New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 17, 2013
09:45 EDTABT, ABT, THOR, THOR, TFX, TFX, SYK, SYK, STJ, STJ, NUVA, NUVA, MDT, MDT, HTWR, HTWR, HSP, HSP, EW, EW, COV, COV, CFN, CFN, BDX, BDX, BSX, BSX, BCR, BCR, BAX, BAX, ZMH, ZMHBarclays' U.S. medical suppplies & devices analysts hold a conference call
U.S. Medical Supplies & Devices Research Team discuss key potential catalysts and top ideas for 2013 on an Analyst/Industry conference call. Relevant covered companies ABT, BAX, BCR, BSX, BDX, CFN, COV, EW, HSP, HTWR, MDT, NUVA, STJ, SYK, TFX, THOR and ZMH will be discussed on the Analyst/Industry conference call to be held January 17 at 10 am.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 >>
December 1, 2015
06:39 EDTBSXNevro patent case win removes possible overhang, says JPMorgan
Subscribe for More Information
November 30, 2015
16:19 EDTBSXBoston Scientific gets FDA appproval, CE Mark for thrombectomy catheter
Subscribe for More Information
16:13 EDTBSXUSPTO denies inter partes review of of Nevro patent
Subscribe for More Information
10:00 EDTTFXOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Cipher Pharmaceuticals (CPHR) initiated with an Outperformer at CIBC... Concordia (CXRX) initiated with a Sector Performer at CIBC... Dynavax (DVAX) initiated with an Outperform at RBC Capital... First Guaranty Bancshares (FGBI) initiated with a Buy at Sandler O'Neill... MGE Energy (MGEE) initiated with a Neutral at Baird... MPLX (MPLX) initiated with a Buy at Ladenburg... Merus Labs (MSLI) initiated with an Outperformer at CIBC... Moelis (MC) initiated with a Buy at Sandler O'Neill... Navient (NAVI) initiated with an Overweight at JPMorgan... Sallie Mae (SLM) initiated with an Overweight at JPMorgan... Teleflex (TFX) initiated with an Overweight at Piper Jaffray... W.R. Grace (GRA) initiated with a Hold at Cantor... WestRock (WRK) initiated with a Buy at Cantor.
08:03 EDTSTJSt. Jude launches Proclaim Elite in Europe
Subscribe for More Information
07:16 EDTSTJSt. Jude Medical management to meet with Deutsche Bank
Subscribe for More Information
06:44 EDTTFXTeleflex initiated with an Overweight at Piper Jaffray
Piper Jaffray analyst Brooks West started Teleflex Incorporated with an Overweight rating and $153 price target.
06:31 EDTNUVAInvuity names Greg Lucier Chairman of the Board
Invuity (IVTY) announced that life sciences industry luminary Gregory Lucier has been appointed to the role of Chairman of its Board, effective December 31, 2015. Lucier, who is the CEO of Nuvasive (NUVA), has served on the Invuity board since October 2014. He will take the place of Gregory Brown, who will resign from the Board effective December 31, 2015.
November 27, 2015
07:29 EDTBAXMarcus Evans to hold a conference
4th Annual Medical Device Safety Monitoring & Reporting Conference is being held in Las Vegas on November 27-28.
06:59 EDTMDTMedtronic volatility flat into Q2 and outlook
Subscribe for More Information
November 24, 2015
08:31 EDTMDTMedtronic remains a top tier performer in Med Device space, says Cowen
Subscribe for More Information
November 23, 2015
17:29 EDTBDXBecton Dickinson raises quarterly dividend 10% to 66c per share
Subscribe for More Information
08:36 EDTBCRC.R. Bard acquisition positive, says JMP Securities
After C.R. Bard agreed to buy Liberator Medical, JMP Securities says the deal "will bring incremental reimbursement expertise, potentially open the door to other chronic disease states, increase direct contact with patients and... provide a tailwind of about 2% to sales and some EPS accretion." The firm reiterates a $207 price target and Outperform rating on C.R. Bard.
November 20, 2015
07:28 EDTBCRLiberator Medical to be acquired by C.R. Bard for $3.35 per share
Subscribe for More Information
07:28 EDTBCRC.R. Bard to acquire Liberator Medical for roughly $181M
C.R. Bard (BCR) announced that it has entered into a definitive agreement to acquire Liberator Medical Holdings (LBMH) for $3.35 per share, or approximately $181M. This transaction is structured as a merger, has been approved by each company's board of directors, and is subject to customary closing conditions, including approval of the shareholders of Liberator and regulatory approvals. The company expects the transaction to close in the first quarter of 2016 and add approximately $70M to 2016 net sales and to be slightly accretive to adjusted cash earnings per share in 2016. The company estimates that in 2017 this acquisition will increase the organic revenue growth rate of the company and contribute between 5c-10c of adjusted cash earnings per share.
05:22 EDTMDTStocks with implied volatility movement; MDT UNH
Stocks with implied volatility movement; Medtronic (MDT) 25, UnitedHealth (UNH) 30 according to iVolatility.
November 19, 2015
16:43 EDTBSXBoston Scientific receives CE Mark for next generation WATCHMAN FLX
Boston Scientific announced that the first implants of the WATCHMAN FLX Left Atrial Appendage Closure, or LAAC, Device - the latest generation of the WATCHMAN Device - occurred in Europe following CE mark approval.
16:34 EDTEWEdwards Lifesciences approves two-for-one stock split
Edwards Lifesciences approved a two-for-one split of the company's outstanding shares of common stock to be effected as a 100% stock dividend. This will be the company's second stock split since it went public in April 2000. Stockholders of record at the close of business on November 30 will be issued one additional share of common stock for each share owned as of that date. The additional shares will be distributed on December 11. The stock split will increase the number of common shares outstanding from approximately 108M shares as of the record date, to approximately 216M shares.
10:42 EDTBSXLeerink medical devices analyst holds an analyst/industry conference call
Subscribe for More Information
08:02 EDTSTJSt. Jude Medical announces FDA approval of Proclaim Elite SCS system
Subscribe for More Information
1 | 2 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use